Dow Down0.36% Nasdaq Down0.53%

Avanir Pharmaceuticals, Inc. (AVNR)

-NMS
6.74 0.02(0.30%) Sep 12, 4:00PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Sep 30, 2012Sep 30, 2011
Net Income (75,476) (59,744) (60,632)
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,423  913  438  
Adjustments To Net Income6,054  4,877  3,788  
Changes In Accounts Receivables(5,502)(5,221)(2,011)
Changes In Liabilities7,766  2,005  4,305  
Changes In Inventories(171)(279)(164)
Changes In Other Operating Activities484  (209)(2,245)
Total Cash Flow From Operating Activities (65,422) (57,657) (56,521)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(448)(813)(1,823)
Investments87  (104)(1,651)
Other Cash flows from Investing Activities -   -   -  
Total Cash Flows From Investing Activities (362) (917) (3,475)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock51,265  19,195  100,192  
Net Borrowings -  29,615  581  
Other Cash Flows from Financing Activities -   -  (6)
Total Cash Flows From Financing Activities 51,265   48,809   100,767  
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents (14,519) (9,764) 40,771  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.